Skip to main content

NUEVOS BIOMATERIALES MAGNETICOS DIRIGIDOS A LA REGENERACION CEREBRAL E IMAGEN MEDICA PARA EL TRATAMIETO DE ICTUS CEREBRAL

PCIN-2017-090

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos Programación Conjunta Internacional
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

PLGA protein nanocarriers with tailor-made fluorescence/MRI/PET imaging modalities

  • Zhang, Yajie
  • García Gabilondo, Miguel
  • Grayston, Alba
  • Feiner, Irene V. J.
  • Anton Sales, Irene
  • Azevedo Loiola, Rodrigo
  • Llop, Jordi
  • Ramos Cabrer, Pedro
  • Barba, Ignasi
  • Garcia Dorado, David
  • Gosselet, Fabien
  • Rosell, Anna
  • Roig Serra, Anna
Designing theranostic nanocarriers with high protein payload and multimodality tracking without cross interferences between the different imaging probes and the delicate protein cargo is challenging. Here, chemical modifications of poly(lactic-co-glycolic acid) (PLGA) to produce nanocapsules (NCs) that incorporate several imaging moieties are reported. The biocompatible and biodegradable PLGA-NCs can be endowed with a magnetic resonance imaging (MRI) reporter, two fluorescence imaging probes (blue/NIR) and a positron emission tomography (PET) reporter. The modular integration of these imaging moieties into the shell of the NCs is successfully achieved without affecting the morphochemical properties of the nanocarrier or the protein loading capacity. In vivo biodistribution of the NCs is monitored by MRI, PET and NIRF and the results from different techniques are analyzed comparatively. The viabilities of two different human endothelial cells in vitro show no toxicity for NC concentration up to 100 μg mL−1 . The morbidity of mice for 2 weeks after systemic administration and the hepatic/pancreatic enzymes at the plasma level indicate their in vivo biosafety. In summary, the new theranostic PLGA nanoplatform presented here shows versatile in vitro/in vivo multimodal imaging capabilities, excellent biosafety and over 1 wt% protein loading., The Acciones Complementarias program from the Instituto de Salud Carlos III, Spain, co-financed by the European Regional Development Fund (AC17/00004 grant) as part of the MAGBBRIS project (Euronanomed III 8th joint call), and the RETICS INVICTUS RD16/0019/0021 are acknowledged. The Miguel Servet program (CPII15/00003) and PFIS program (FI17/00073) from Fondo de Investigaciones SanitariasInstituto de Salud Carlos III and ERDF supported A. Rosell and A. G. research contracts. This work was also partially supported by the Spanish Ministry of Science, Innovation and Universities through the grants PCIN-2017-090, RTI2018- 096273-B-I00, CTQ2017-87637-R, SAF2017-87670-R, SEV-2015- 0496 and MDM-2017-0720 and by the Generalitat de Catalunya grants (2017SGR765 & 2017SGR1427). Yajie Zhang is supported by the China Scholarship Council (CSC). FG and RAL are supported by the French national agency (ANR) through the grant ANR-17-ENM3-0005-01. The authors thank Dr Vanessa GómezVallejo, Dr Unai Cossío, Dr Xabier Rios and Zuriñe Baz for support in labelling and PET in vivo experimentation. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics

  • Zhang, Yajie
  • García Gabilondo, Miguel
  • Rosell, Anna
  • Roig Serra, Anna
Developing multifunctional and biocompatible drug delivery nanoplatforms that integrate high drug loads and multiple imaging modalities avoiding cross-interferences is extremely challenging. Here we report on the successful chemical reaction of the high quantum yield biodegradable and photoluminescent polyester (BPLP) with the poly(lactic-co-glycolic acid) (PLGA) polymer to fabricate biocompatible photoluminescent nanocapsules (NCs). Furthermore, we transform the PLGA-BPLP NCs into a magnetic resonance (MR)/photoluminescence dual-modal imaging theranostic platform by incorporating superparamagnetic iron oxide nanoparticles (SPIONs) into the polymeric shell. In vitro phantoms confirmed the excellent MRI-r2 relaxivity values of the NCs whilst the cellular uptake of these NCs was clearly observed by fluorescence optical imaging. Besides, the NCs (mean size ~270 nm) were loaded with ~1 wt% of a model protein (BSA) and their PEGylation provided a more hydrophilic surface. The NCs show biocompatibility in vitro, as hCMEC/D3 endothelial cells viability was not affected for particle concentration up to 500 μg/mL. Interestingly, NCs decorated with SPIONs can be exploited for magnetic guiding and retention., This work was partially supported by the Spanish Ministry of Science, Innovation and Universities through the grants PCIN-2017-090, RTI2018-096273-B-I00, CTQ2017-87637-R, SAF2017-87670-R, SEV-2015-0496 and MDM-2017-0720 and by the Generalitat de Catalunya grants (2017SGR765 & 2017SGR1427). Yajie Zhang was supported by the China Scholarship Council (CSC). The Acciones Complementarias program from the Instituto de Salud Carlos III, Spain, co-financed by the European Regional Development Fund (AC17/00004 grant) as part of the MAGBBRIS project (Euronanomed III 8th joint call), and the RETICS INVICTUS RD16/0019/0021 were acknowledged. Miguel Servet program (CPII15/00003) from Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III and ERDF, supported A. Roig research contract., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Central nervous system delivery of molecules across the blood-brain barrier

  • Gosselet, Fabien
  • Azevedo Loiola, Rodrigo
  • Roig Serra, Anna
  • Rosell, Anna
  • Culot, Maxime
Therapies targeting neurological conditions such as Alzheimer's or Parkinson's diseases are hampered by the presence of the blood-brain barrier (BBB). During the last decades, several approaches have been developed to overcome the BBB, such as the use of nanoparticles (NPs) based on biomaterials, or alternative methods to open the BBB. In this review, we briefly highlight these strategies and the most recent advances in this field. Limitations and advantages of each approach are discussed. Combination of several methods such as functionalized NPs targeting the receptor-mediated transcytosis system with the use of magnetic resonance imaging-guided focused ultrasound (FUS) might be a promising strategy to develop theranostic tools as well as to safely deliver therapeutic molecules, such as drugs, neurotrophic factors or antibodies within the brain parenchyma., This work has been supported under the Euronanomed 8th Joint Call-MAGGBRIS collaborative project by grants from the Spanish Ministry of Science and Innovation (PCIN-2017-090) and Instituto Salud Carlos III (AC17/00004 with FEDER funds) and from the French national agency (ANR-ANR-17-ENM3-0005-01) for FG and RAL. This work has also been supported by the SGR program (2017SGR1427 and 2017SGR765 grants) from the Generalitat de Catalunya. MC thanks the support of the ANR in the framework of the Diasyn project (ERA-Net Euronanomed II JTC2015 grant number: ANR-15 -ENM2 -0002-06)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Copper Oxide Nanocubes Wrapping Metals by Microwave Synthesis

  • Torras, Miquel
  • Roig Serra, Anna
Copper and copper oxide nanoparticles (NPs) are industrially important. In particular, Cu-based nanocatalysts find applicability in electrocatalysis and photocatalysis, profiting from the accessible oxidation states of copper and a band gap in the visible region of the Cu2O phase. However, in this case, the fast recombination of the charge carriers compromises the final photocatalytic efficiency. The combination of Cu2O with metals often results in higher and more stable photocatalytic efficiency. Here, the fabrication of noble metal NPs [Au, Ag, Pd, and Pt] and Cu2O heterostructures (HSs) by a microwave (MW)-assisted synthesis is presented. The selectivity of the MW technique with a fast two-step protocol enabled us to easily prepare these multicomponent nanoparticles in a short time (∼40 min). First, metal NPs (Au, Ag, or Pd) are synthesized through a MW-assisted polyol approach, and these NPs serve as nucleation seeds for cubic Cu2O wrapping. Other types of heterostructures were found when using smaller Pt NPs instead. Focusing on Au NPs as the core, we analyzed the effect of the gold to copper molar ratio on the shape yield of the nanocubes, reported their optic and plasmonic properties, and demonstrated the reproducibility and scalability of the synthetic routes. Here, we are providing a pioneering example of MW heating as a non-conventional energy source for a general chemical approach to attain a family of complex metal/metal oxide heterostructures., This research received funding from the Spanish Ministry of Science, Innovation and Universities through the PCIN-2017-090 project, the ‘Severo Ochoa’ Programme for Centers of Excellence in R&D grants (CEX2019-000917-S) and the Generalitat de Catalunya (2017SGR765 grant). The Spanish Ministry of Education, Culture and Sport is funding the FPU Fellow of MT (FPU16/05452). MT is enrolled in the Materials Science Ph.D. Program of the UAB (Universitat Autònoma de Barcelona). The authors would also like to thank Judith Oró from the TEM service at ICMAB, Ana Esther Carrillo from the SEM service at ICMAB, and Belén Ballesteros from the HRTEM service at ICN2., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Endovascular administration of magnetized nanocarriers targeting brain delivery after stroke

  • Grayston, Alba
  • Zhang, Yajie
  • García Gabilondo, Miguel
  • Arrue, Mercedes
  • Martín, Abraham
  • Kopcansky, Peter
  • Timko, Milan
  • Kováč, Jozef
  • Strbak, Oliver
  • Castellote, Laura
  • Belloli, Sara
  • Moresco, Rosa M.
  • Picchio, Maria
  • Roig Serra, Anna
  • Rosell, Anna
The increasing use of mechanical thrombectomy in stroke management has opened the window to local intraarterial brain delivery of therapeutic agents. In this context, the use of nanomedicine could further improve the delivery of new treatments for specific brain targeting, tracking and guidance. In this study we take advantage of this new endovascular approach to deliver biocompatible poly(D-L-lactic-co-glycolic acid) (PLGA) nanocapsules functionalized with superparamagnetic iron oxide nanoparticles and Cy7.5 for magnetic targeting, magnetic resonance and fluorescent molecular imaging. A complete biodistribution study in naïve (n = 59) and ischemic (n = 51) mice receiving intravenous or intraarterial nanocapsules, with two different magnet devices and imaged from 30 min to 48 h, showed an extraordinary advantage of the intraarterial route for brain delivery with a specific improvement in cortical targeting when using a magnetic device in both control and ischemic conditions. Safety was evaluated in ischemic mice (n = 69) showing no signs of systemic toxicity nor increasing mortality, infarct lesions or hemorrhages. In conclusion, the challenging brain delivery of therapeutic nanomaterials could be efficiently and safely overcome with a controlled endovascular administration and magnetic targeting, which could be considered in the context of endovascular interventions for the delivery of multiple treatments for stroke., We are grateful for the technical assistance received from the Pre-clinical imaging Platform at Vall d’Hebron Institut de Recerca, the Servei RMN at Universitat Autònoma de Barcelona, and the Unitat de Microscopia Òptica Avançada, Facultat de Medicina at the Universitat de Barcelona. This work has been supported under the Euronanomed MAGGBRIS collaborative project by grants from the Spanish Ministry of Science and Innovation (PCIN-2017-090 grant), the Instituto de Salud Carlos III (AC17/00004 with FEDER funds), the Slovak Research and Development Agency under the Contract No.APVV-19-0324 and the Italian Ministry of Health (Ricerca Corrente year 2017 funds); by the Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019 P-CMR[C]); programs 2017-SGR-1427 and 2017-SGR-765 from the Generalitat de Catalunya; RETICS-INVICTUS PLUS from ISCIII (RD16/0019/0021 with FEDER funds); the ‘Severo Ochoa’ Program for Centers of Excellence in R&D (SEV-2015-0496) and the RYC-2017- 22412 and PID2019-107989RB-I00. A.G has been supported by fellowships from ISCIII (FI17/00073 and MV18/00006), A.R by a visiting-scientist fellowship from ISCIII (BA17/00052) and Y. Z has been supported by the China Scholarship Council (CSC)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MRI/Photoluminescence Dual-Modal Imaging Magnetic PLGA Nanocapsules for Theranostics

  • Zhang, Yajie|||0000-0003-1566-1007
  • García-Gabilondo, Miguel|||0000-0002-2015-2621
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Roig i Serra, Anna|||0000-0001-6464-7573
Developing multifunctional and biocompatible drug delivery nanoplatforms that integrate high drug loads and multiple imaging modalities avoiding cross-interferences is extremely challenging. Here we report on the successful chemical reaction of the high quantum yield biodegradable and photoluminescent polyester (BPLP) with the poly(lactic-co-glycolic acid) (PLGA) polymer to fabricate biocompatible photoluminescent nanocapsules (NCs). Furthermore, we transform the PLGA-BPLP NCs into a magnetic resonance (MR)/photoluminescence dual-modal imaging theranostic platform by incorporating superparamagnetic iron oxide nanoparticles (SPIONs) into the polymeric shell. In vitro phantoms confirmed the excellent MRI-r relaxivity values of the NCs whilst the cellular uptake of these NCs was clearly observed by fluorescence optical imaging. Besides, the NCs (mean size ~270 nm) were loaded with ~1 wt% of a model protein (BSA) and their PEGylation provided a more hydrophilic surface. The NCs show biocompatibility in vitro, as hCMEC/D3 endothelial cells viability was not affected for particle concentration up to 500 μg/mL. Interestingly, NCs decorated with SPIONs can be exploited for magnetic guiding and retention.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage

  • Loiola, Rodrigo Azevedo
  • García-Gabilondo, Miguel|||0000-0002-2015-2621
  • Grayston, Alba|||0000-0002-1466-0099
  • Bugno, Paulina
  • Kowalska, Agnieszka
  • Duban-Deweer, Sophie
  • Rizzi, Eleonora
  • Hachani, Johan
  • Sano, Yasuteru
  • Shimizu, Fumitaka
  • Kanda, Takashi
  • Mysiorek, Caroline
  • Mazurek, Maciej Piotr
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Gosselet, Fabien
Background: Cell-based therapeutic strategies have been proposed as an alternative for brain repair after stroke, but their clinical application has been hampered by potential adverse effects in the long term. The present study was designed to test the effect of the secretome of endothelial progenitor cells (EPCs) from stroke patients (scCM) on in vitro human models of angiogenesis and vascular barrier. Methods: Two different scCM batches were analysed by mass spectrometry and a proteome profiler. Human primary CD34-derived endothelial cells (CD34-ECs) were used for designing angiogenesis studies (proliferation, migration, and tubulogenesis) or in vitro models of EC monolayer (confluent monolayer ECs-CMECs) and blood-brain barrier (BBB; brain-like ECs-BLECs). Cells were treated with scCM (5 μg/mL) or protein-free endothelial basal medium (scEBM-control). CMECs or BLECs were exposed (6 h) to oxygen-glucose deprivation (OGD) conditions (1% oxygen and glucose-free medium) or normoxia (control-5% oxygen, 1 g/L of glucose) and treated with scCM or scEBM during reoxygenation (24 h). Results: The analysis of different scCM batches showed a good reproducibility in terms of protein yield and composition. scCM increased CD34-EC proliferation, tubulogenesis, and migration compared to the control (scEBM). The proteomic analysis of scCM revealed the presence of growth factors and molecules modulating cell metabolism and inflammatory pathways. Further, scCM decreased the permeability of CMECs and upregulated the expression of the junctional proteins such as occludin, VE-cadherin, and ZO-1. Such effects were possibly mediated through the activation of the interferon pathway and a moderate downregulation of Wnt signalling. Furthermore, OGD increased the permeability of both CMECs and BLECs, while scCM prevented the OGD-induced vascular leakage in both models. These effects were possibly mediated through the upregulation of junctional proteins and the regulation of MAPK/VEGFR2 activity. Conclusion: Our results suggest that scCM promotes angiogenesis and the maturation of newly formed vessels while restoring the BBB function in ischemic conditions. In conclusion, our results highlight the possibility of using EPC-secretome as a therapeutic alternative to promote brain angiogenesis and protect from ischemia-induced vascular leakage.